Original language | English (US) |
---|---|
Pages (from-to) | 382-385 |
Number of pages | 4 |
Journal | Journal of the American Academy of Dermatology |
Volume | 90 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2024 |
Funding
Funding sources: Research sponsored by Sanofi and Regeneron Pharmaceuticals Inc . Medical writing and editorial assistance were provided by Liselotte Delden of Excerpta Medica, and funded by Sanofi and Regeneron Pharmaceuticals Inc , according to the Good Publication Practice guideline. Funding sources: Research sponsored by Sanofi and Regeneron Pharmaceuticals Inc. Medical writing and editorial assistance were provided by Liselotte Delden of Excerpta Medica, and funded by Sanofi and Regeneron Pharmaceuticals Inc, according to the Good Publication Practice guideline.
Keywords
- NRS
- atopic dermatitis
- clinically meaningful
- dupilumab
- itch
- pediatric
- pruritus
- psychometric
- responder threshold
- validation
ASJC Scopus subject areas
- Dermatology